This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Ratiopharm Gmbh. Active years: 2019-2020.
Company Filing History:
Years Active: 2019-2020
Title: Innovations of David Perez Palacios
Introduction
David Perez Palacios is a notable inventor based in Singen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of co-crystals for drug formulations. With a total of 2 patents to his name, his work has the potential to enhance the efficacy of important medications.
Latest Patents
Among his latest patents, one focuses on "Methods of preparing co-crystals of ibrutinib with carboxylic acids." This invention relates to the creation of co-crystals of ibrutinib, a drug used in the treatment of certain types of cancer, and a pharmaceutical composition that includes these co-crystals. Another patent also addresses "Co-crystals of ibrutinib with carboxylic acids," emphasizing the importance of this innovative approach in pharmaceutical applications.
Career Highlights
David is currently employed at Ratiopharm GmbH, a prominent pharmaceutical company known for its commitment to developing high-quality medications. His work at Ratiopharm has allowed him to focus on innovative drug formulations that can improve patient outcomes.
Collaborations
Throughout his career, David has collaborated with esteemed colleagues such as Wolfgang Albrecht and Jens Geier. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.
Conclusion
David Perez Palacios is a dedicated inventor whose work in co-crystal technology has the potential to revolutionize pharmaceutical formulations. His contributions to the field are noteworthy and reflect his commitment to improving healthcare through innovation.